A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity
- Status
- COMPLETED
- Phase
- PHASE1
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
TPO-Mimetic Use in Children for Hematopoietic Failure
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL
- Status
- WITHDRAWN
- Phase
- PHASE2
KRDI in Transplant-Eligible MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant T-VEC in High Risk Early Melanoma
- Status
- SUSPENDED
- Phase
- PHASE2
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
- Status
- COMPLETED
- Phase
- PHASE2
Health Economy Register
- Status
- COMPLETED
- Phase
- N/A
AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).
- Status
- COMPLETED
- Phase
- PHASE1
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
- Status
- COMPLETED
- Phase
- N/A
Study of AMG 256 in Adult Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of AMG 714 for Vitiligo
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease
- Status
- COMPLETED
- Phase
- PHASE2
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Status
- RECRUITING
- Phase
- PHASE3
Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab
- Status
- COMPLETED
- Phase
- PHASE2